EDRS
GSK icon

Edmond de Rothschild (Suisse)’s GSK GSK Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-455
Closed -$25K – 469
2016
Q2 		$25K Hold
455
– – 0.01% 339
2016
Q1 		$23K Hold
455
– – 0.01% 304
2015
Q4 		$23K Hold
455
– – 0.01% 305
2015
Q3 		$22K Hold
455
– – 0.01% 338
2015
Q2 		$24K Buy
+455
New +$25.6K 0.01% 331

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s GSK Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) sold out of GSK (GSK) in Q3 2016, closing a stake of 455 shares — an estimated $25K sold.

Edmond de Rothschild (Suisse) first reported a position in GSK in Q2 2015 and held it in 5 quarters. The position peaked at $25K in Q2 2016. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

  • Edmond de Rothschild (Suisse) reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
  • Edmond de Rothschild (Suisse) sold 455 GSK shares in Q3 2016, an estimated $25K.
  • Edmond de Rothschild (Suisse) first reported a position in GSK in Q2 2015 and held it in 5 quarters.
  • Edmond de Rothschild (Suisse)'s GSK position peaked at $25K in Q2 2016.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.